BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pulvirenti F, Fernandez Salinas A, Milito C, Terreri S, Piano Mortari E, Quintarelli C, Di Cecca S, Lagnese G, Punziano A, Guercio M, Bonanni L, Auria S, Villani F, Albano C, Locatelli F, Spadaro G, Carsetti R, Quinti I. B Cell Response Induced by SARS-CoV-2 Infection Is Boosted by the BNT162b2 Vaccine in Primary Antibody Deficiencies. Cells 2021;10:2915. [PMID: 34831138 DOI: 10.3390/cells10112915] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Quinti I, Locatelli F, Carsetti R. The Immune Response to SARS-CoV-2 Vaccination: Insights Learned From Adult Patients With Common Variable Immune Deficiency. Front Immunol 2022;12:815404. [DOI: 10.3389/fimmu.2021.815404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Abo-Helo N, Muhammad E, Ghaben-Amara S, Cohen S. Specific antibody response of 14 patients with common variable immunodeficiency to 3 BNT162b2 messenger RNA coronavirus disease 2019 vaccinations. Ann Allergy Asthma Immunol 2022;129:108-9. [PMID: 35398265 DOI: 10.1016/j.anai.2022.03.035] [Reference Citation Analysis]
3 Garzi G, Cinetto F, Firinu D, Di Napoli G, Lagnese G, Punziano A, Bez P, Cinicola BL, Costanzo G, Scarpa R, Pulvirenti F, Rattazzi M, Spadaro G, Quinti I, Milito C. Real-life data on monoclonal antibodies and antiviral drugs in Italian inborn errors of immunity patients during COVID-19 pandemic. Front Immunol 2022;13:947174. [DOI: 10.3389/fimmu.2022.947174] [Reference Citation Analysis]
4 Goda V, Kriván G, Kulcsár A, Gönczi M, Tasnády S, Matula Z, Nagy G, Bekő G, Horváth M, Uher F, Szekanecz Z, Vályi-nagy I. Specific Antibody and the T-Cell Response Elicited by BNT162b2 Boosting After Two ChAdOx1 nCoV-19 in Common Variable Immunodeficiency. Front Immunol 2022;13:907125. [DOI: 10.3389/fimmu.2022.907125] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zimmerman O, Altman Doss AM, Kaplonek P, Liang CY, VanBlargan LA, Chen RE, Monroy JM, Wedner HJ, Kulczycki A Jr, Mantia TL, O'Shaughnessy CC, Davis-Adams HG, Bertera HL, Adams LJ, Raju S, Zhao FR, Rigell CJ, Dy TB, Kau AL, Ren Z, Turner JS, O'Halloran JA, Presti RM, Fremont DH, Kendall PL, Ellebedy AH, Alter G, Diamond MS. mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes. Cell Rep Med 2022;3:100653. [PMID: 35688161 DOI: 10.1016/j.xcrm.2022.100653] [Reference Citation Analysis]
6 Zaffina S, Piano Mortari E, Di Prinzio RR, Cappa M, Novelli A, Agolini E, Raponi M, Dallapiccola B, Locatelli F, Perno CF, Carsetti R. Case Report: Precision COVID-19 Immunization Strategy to Overcome Individual Fragility: A Case of Generalized Lipodystrophy Type 4. Front Immunol 2022;13:869042. [PMID: 35464479 DOI: 10.3389/fimmu.2022.869042] [Reference Citation Analysis]
7 Quinti I. Cellular Immunology and COVID-19. Cells 2021;10:3591. [PMID: 34944098 DOI: 10.3390/cells10123591] [Reference Citation Analysis]
8 Pulvirenti F, Di Cecca S, Sinibaldi M, Piano Mortari E, Terreri S, Albano C, Guercio M, Sculco E, Milito C, Ferrari S, Locatelli F, Quintarelli C, Carsetti R, Quinti I. T-Cell Defects Associated to Lack of Spike-Specific Antibodies after BNT162b2 Full Immunization Followed by a Booster Dose in Patients with Common Variable Immune Deficiencies. Cells 2022;11:1918. [PMID: 35741048 DOI: 10.3390/cells11121918] [Reference Citation Analysis]
9 Green NS, Van Doren L, Licursi M, Billings DD, Sandoval LA, Feit YMZ, Hod EA. Anti-SARS-CoV-19 antibodies in children and adults with sickle cell disease: A single-site analysis in New York City. Br J Haematol 2022. [PMID: 35759223 DOI: 10.1111/bjh.18294] [Reference Citation Analysis]